MARKER THERAPEUTICS, INC. Assets, Noncurrent
MARKER THERAPEUTICS, INC. (MRKR) had Assets, Noncurrent of $17.03 million as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AssetsNoncurrent · last filed 2023-05-15
- 2023-03-31: Assets, Noncurrent $17.03M.
- 2022-12-31: Assets, Noncurrent $17.80M.
- 2022-09-30: Assets, Noncurrent $18.69M.
- 2022-06-30: Assets, Noncurrent $23.04M.
| Period end | Assets, Noncurrent |
|---|---|
| 2023-03-31 | $17.03M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $17.80M 10-Q · filed 2023-05-15 |
| 2022-09-30 | $18.69M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $23.04M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $23.94M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $22.15M 10-K · filed 2023-03-22 |
| 2021-09-30 | $20.53M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $20.45M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $20.89M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $21.20M 10-K · filed 2022-03-17 |
| 2020-09-30 | $18.25M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $13.76M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $889.90K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $872.70K 10-K · filed 2021-03-09 |
| 2019-09-30 | $940.60K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $960.69K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $952.70K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $147.67K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |